COT-21 EFFECT OF BEVACIZUMAB FOR PEDIATRIC HIGH GRADE GLIOMA

INTRODUCTION: Bevacizumab (BEV) therapy has been used for pediatric high grade glioma,however the evidence and effectiveness are not understood yet. METHODS: We report 7 cases (age 2 to 10 years old) of pediatric high grade glioma treated with BEV. One case is thalamic diffuse midline glioma H3K27 m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurooncol Adv
Main Authors: Tsukamoto, Yoshihiro, Natsumeda, Manabu, Okada, Masayasu, Eda, Takeyoshi, Yoshimura, Junichi, Okamoto, Kouichirou, Oishi, Makoto, Fujii, Yukihiko
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2019
Assuntos:
Abstracts
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213162/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.201
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares